Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (421-430 of 555) with videos related to

Pageof 56
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteersRosa F Yeh, Vincent E Gaver, Kristine B Patterson, et al.
Vaccine|April 8, 2004
Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cellsMaria G Isaguliants, Natalia V Petrakova, Elena V Kashuba, et al.
International Journal of Molecular Sciences|December 4, 2012
NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancerVladimir Kashuba, Alexey A Dmitriev, George S Krasnov, et al.
AIDS (London, England)|August 28, 2007
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxisJulie B Dumond, Rosa F Yeh, Kristine B Patterson, et al.
FEBS Letters|January 15, 1998
NotI linking/jumping clones of human chromosome 3: mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumorsV I Kashuba, R Z Gizatullin, A I Protopopov, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|April 30, 2019
Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician PerspectivesLauren M Hill, Carol E Golin, Allison Pack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.
The Journal of Infectious Diseases|April 20, 2011
Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative menKevin C Brown, Kristine B Patterson, Stephanie A Malone, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
The pharmacokinetics and viral activity of tenofovir in the male genital tractManoli Vourvahis, Hiba L Tappouni, Kristine B Patterson, et al.
Pageof 56

Showing results (421-430 of 555) with videos related to

Sort By:
Pageof 56
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteersRosa F Yeh, Vincent E Gaver, Kristine B Patterson, et al.
Vaccine|April 8, 2004
Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cellsMaria G Isaguliants, Natalia V Petrakova, Elena V Kashuba, et al.
International Journal of Molecular Sciences|December 4, 2012
NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancerVladimir Kashuba, Alexey A Dmitriev, George S Krasnov, et al.
AIDS (London, England)|August 28, 2007
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxisJulie B Dumond, Rosa F Yeh, Kristine B Patterson, et al.
FEBS Letters|January 15, 1998
NotI linking/jumping clones of human chromosome 3: mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumorsV I Kashuba, R Z Gizatullin, A I Protopopov, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|April 30, 2019
Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician PerspectivesLauren M Hill, Carol E Golin, Allison Pack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.
The Journal of Infectious Diseases|April 20, 2011
Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative menKevin C Brown, Kristine B Patterson, Stephanie A Malone, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesM Cohen-Wolkowiez, D K Benjamin, L Piper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
The pharmacokinetics and viral activity of tenofovir in the male genital tractManoli Vourvahis, Hiba L Tappouni, Kristine B Patterson, et al.
Pageof 56